Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| VivoSim Labs, INC.ONVO · Entity 8386 | General Manager | August 16, 2019 | August 19, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
VivoSim Labs, INC.
Report date August 16, 2019 · Filed August 19, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 191,335 |
Reported balance
After 2019-08-16 transaction · row 1
1 source rowRow 1 · 2019-08-16 · Tax withholding · Disposed 9,500 · Balance 191,335 F1: Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted in July 2016, June 2017 and May 2018, pursuant to the Reporting Person's agreement with the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted in July 2016, June 2017 and May 2018, pursuant to the Reporting Person's agreement with the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 16, 2019 Filed Aug 19, 2019 22:21 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | Tax withholdingCommon Stock | 9,500 | $0.29 | $2,713.20 |
DisclosureSEC source: 0001209191-19-046691 · doc4.xml · nonDerivative · entry 1 Gallant Paul · CIK 0001651405 · General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,335 F1 · shares: Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted in July 2016, June 2017 and May 2018, pursuant to the Reporting Person's agreement with the Issuer. Read SEC document |
| May 16, 2019 Filed May 20, 2019 21:45 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | Tax withholdingCommon Stock | 9,274 | $0.97 | $8,995.78 |
DisclosureSEC source: 0001209191-19-031494 · doc4.xml · nonDerivative · entry 1 Gallant Paul · CIK 0001651405 · General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,835 F1 · shares: Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted in July 2016, June 2017 and May 2018, pursuant to the Reporting Person's agreement with the Issuer. F2 · balance_after: This number does not include 1,036,667 shares of common stock underlying outstanding options held by Mr. Gallant; post-transaction Mr. Gallant beneficially owns or has a right to acquire 1,237,502 shares of common stock. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 22:54 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | Tax withholdingCommon Stock | 10,410 | $1.07 | $11,093.94 |
DisclosureSEC source: 0001209191-19-012225 · doc4.xml · nonDerivative · entry 1 Gallant Paul · CIK 0001651405 · General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,109 F1 · shares: Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted in July 2016, June 2017 and May 2018, pursuant to the Reporting Person's agreement with the Issuer. F2 · balance_after: This number does not include 1,036,667 shares of common stock underlying outstanding options held by Mr. Gallant; post-transaction Mr. Gallant beneficially owns or has a right to acquire 1,246,776 shares of common stock. Read SEC document |
| November 16, 2018 Filed Nov 20, 2018 22:45 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | Tax withholdingCommon Stock | 9,450 | $1.07 | $10,085.99 |
DisclosureSEC source: 0001209191-18-059496 · doc4.xml · nonDerivative · entry 1 Gallant Paul · CIK 0001651405 · General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,519 F1 · shares: Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted in July 2016, June 2017 and May 2018, pursuant to the Reporting Person's agreement with the Issuer. F2 · balance_after: This number does not include 1,036,667 shares of common stock underlying outstanding options held by Mr. Gallant; post-transaction Mr. Gallant beneficially owns or has a right to acquire 1,257,186 shares of common stock. Read SEC document |
| August 16, 2018 Filed Aug 16, 2018 23:01 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | Tax withholdingCommon Stock | 9,835 | $1.11 | $10,892.26 |
DisclosureSEC source: 0001209191-18-047200 · doc4.xml · nonDerivative · entry 1 Gallant Paul · CIK 0001651405 · General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,969 F1 · shares: Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted in July 2016, June 2017 and May 2018, pursuant to the Reporting Person's agreement with the Issuer. F2 · balance_after: This number does not include 1,036,667 shares of common stock underlying outstanding options held by Mr. Gallant; post-transaction Mr. Gallant beneficially owns or has a right to acquire 1,266,636 shares of common stock. Read SEC document |
| May 24, 2018 Filed May 29, 2018 21:39 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | GrantStock Option (Right to Buy) · Derivative | 266,667 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0001209191-18-033921 · doc4.xml · derivative · entry 2 Gallant Paul · CIK 0001651405 · General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,667 Underlying: Common Stock · 266,667 shares Expires 2028-05-24 F4 · derivative.exercise_date: The option shares vest and become exercisable over 16 equal quarterly installments measured from May 15, 2018. Read SEC document |
| May 24, 2018 Filed May 29, 2018 21:39 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | GrantCommon Stock | 66,115 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-033921 · doc4.xml · nonDerivative · entry 1 Gallant Paul · CIK 0001651405 · General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,804 F1 · security: Annual long-term equity award approved by the Compensation Committee of the Issuer's Board of Directors. F2 · shares: The shares represent a grant of Restricted Stock Units ("RSUs"). The RSUs represent a right to receive shares of the Issuer's common stock, at no additional conversion or exercise price. The RSUs vest and settle over 16 equal quarterly installments measured from May 15, 2018. F3 · balance_after: This number does not include 586,667 shares of common stock underlying outstanding options held by Mr. Gallant; post-transaction Mr. Gallant beneficially owns or has a right to acquire 826,471 shares of common stock. Read SEC document |
| May 16, 2018 Filed May 17, 2018 21:40 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | Tax withholdingCommon Stock | 6,890 | $1.66 | $11,451.87 |
DisclosureSEC source: 0001209191-18-031107 · doc4.xml · nonDerivative · entry 1 Gallant Paul · CIK 0001651405 · General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,689 F1 · shares: Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted in July 2016 and June 2017, pursuant to the Reporting Person's agreement with the Issuer. F2 · balance_after: This number does not include 320,000 shares of common stock underlying outstanding options held by Mr. Gallant; post-transaction Mr. Gallant beneficially owns or has a right to acquire 493,689 shares of common stock. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 13:51 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | Tax withholdingCommon Stock | 7,820 | $1.09 | $8,488.61 |
DisclosureSEC source: 0001209191-18-011101 · doc4.xml · nonDerivative · entry 1 Gallant Paul · CIK 0001651405 · General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,579 F1 · shares: Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted in July 2016 and June 2017, pursuant to the Reporting Person's agreement with the Issuer. F2 · balance_after: This number does not include 320,000 shares of common stock underlying outstanding options held by Mr. Gallant; post-transaction Mr. Gallant beneficially owns or has a right to acquire 500,579 shares of common stock. Read SEC document |
| November 16, 2017 Filed Nov 17, 2017 00:47 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | Tax withholdingCommon Stock | 7,015 | $1.47 | $10,313.45 |
DisclosureSEC source: 0001209191-17-061325 · doc4.xml · nonDerivative · entry 1 Gallant Paul · CIK 0001651405 · General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,399 F1 · shares: Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted in July 2016 and June 2017, pursuant to the Reporting Person's agreement with the Issuer. F2 · balance_after: This number does not include 320,000 shares of common stock underlying outstanding options held by Mr. Gallant; post-transaction Mr. Gallant beneficially owns or has a right to acquire 508,399 shares of common stock. Read SEC document |
| August 16, 2017 Filed Aug 17, 2017 20:50 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | Tax withholdingCommon Stock | 7,324 | $2.06 | $15,087.44 |
DisclosureSEC source: 0001209191-17-049423 · doc4.xml · nonDerivative · entry 1 Gallant Paul · CIK 0001651405 · General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,414 F1 · shares: Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted in July 2016 and June 2017, pursuant to the Reporting Person's agreement with the Issuer. F2 · balance_after: This number does not include 320,000 shares of common stock underlying outstanding options held by Mr. Gallant; post-transaction Mr. Gallant beneficially owns or has a right to acquire 515,414 shares of common stock. Read SEC document |
| June 27, 2017 Filed Jun 29, 2017 21:14 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | GrantCommon Stock | 160,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-042351 · doc4.xml · nonDerivative · entry 1 Gallant Paul · CIK 0001651405 · General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,738 F1 · security: Annual long-term equity award approved by the Compensation Committee of the Issuer's Board of Directors. F2 · shares: The shares represent a grant of Restricted Stock Units ("RSUs"). The RSUs represent a right to receive shares of the Issuer's common stock, at no additional conversion or exercise price. The RSUs vest and settle over 16 equal quarterly installments measured from May 15, 2017. F3 · balance_after: This number does not include 325,000 shares of common stock underlying outstanding options held by Mr. Gallant; post-transaction Mr. Gallant beneficially owns or has a right to acquire 527,738 shares of common stock. Read SEC document |
| May 16, 2017 Filed May 17, 2017 23:09 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | Tax withholdingCommon Stock | 1,317 | $2.86 | $3,769.39 |
DisclosureSEC source: 0001209191-17-033416 · doc4.xml · nonDerivative · entry 1 Gallant Paul · CIK 0001651405 · General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,738 F1 · shares: Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted in July 2016, pursuant to the Reporting Person's agreement with the Issuer. F2 · balance_after: This number does not include 320,000 shares of common stock underlying outstanding options held by Mr. Gallant; post-transaction Mr. Gallant continues to beneficially own or have a right to acquire 362,738 shares of common stock. Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 23:00 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | Tax withholdingCommon Stock | 1,320 | $2.95 | $3,894.00 |
DisclosureSEC source: 0001209191-17-012851 · doc4.xml · nonDerivative · entry 1 Gallant Paul · CIK 0001651405 · General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,055 F1 · shares: Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted in July 2016, pursuant to the Reporting Person's agreement with the Issuer. F2 · balance_after: This number does not include 320,000 shares of common stock underlying outstanding options held by Mr. Gallant; post-transaction Mr. Gallant continues to beneficially own or have a right to acquire 364,055 shares of common stock. Read SEC document |
| November 16, 2016 Filed Nov 18, 2016 22:07 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | Tax withholdingCommon Stock | 1,160 | $3.26 | $3,780.90 |
DisclosureSEC source: 0001209191-16-151272 · doc4.xml · nonDerivative · entry 1 Gallant Paul · CIK 0001651405 · General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,375 F1 · shares: Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted in July 2016, pursuant to the Reporting Person's agreement with the Issuer. F2 · balance_after: This number does not include 320,000 shares of common stock underlying outstanding options held by Mr. Gallant; post-transaction Mr. Gallant continues to beneficially own or have a right to acquire 365,375 shares of common stock. Read SEC document |
| August 15, 2008 Filed Aug 16, 2018 23:01 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | GrantStock Option (Right to Buy) · Derivative | 450,000 | $0.00 Strike: $1.14 | $0.00 |
DisclosureSEC source: 0001209191-18-047200 · doc4.xml · derivative · entry 2 Gallant Paul · CIK 0001651405 · General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 450,000 shares Expires 2028-08-15 F3 · derivative.exercise_date: 25% of the option shares vest and become exercisable on August 15, 2019 and the remaining shares vest in 12 equal quarterly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.